Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Papaseit

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Anales De Pediatria|May 10, 2023
Thalidomide, the story goes onEsther Papaseit, Magí Farré, Óscar Garcia-Algar
Current Opinion in Psychiatry|May 21, 2014
Emerging drugs in EuropeEsther Papaseit, Magí Farré, Fabrizio Schifano, et al.
Medicina Clinica|October 23, 2013
[Abuse-related adverse drug reactions and abuse deterrent formulations]Esther Papaseit, Clara Pérez-Mañá, Marta Torrens, et al.
Actas Espanolas De Psiquiatria|February 7, 2019
Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case reportPilar Alvarez, Esther Papaseit, Víctor Pérez, et al.
Medicina (Kaunas, Lithuania)|August 23, 2020
UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of ConsumersManuela Pellegrini, Emilia Marchei, Esther Papaseit, et al.
Pharmaceutics|March 27, 2025
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in HumansDolly Andrea Caicedo, Clara Pérez-Mañá, Magí Farré, et al.
Medicina Clinica|July 30, 2023
[The new trend of some inhalant use: Risks and warnings of false harmlessness]Jose Cárdenas-Quesada, Clara Pérez-Mañá, Esther Papaseit, et al.
JAMA Network Open|January 16, 2019
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysisMari Carmen Torres-Moreno, Esther Papaseit, Marta Torrens, et al.
CNS & Neurological Disorders Drug Targets|April 18, 2017
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and MedicinesAna Lucia Arellano, Esther Papaseit, Anna Romaguera, et al.
CNS & Neurological Disorders Drug Targets|April 26, 2017
Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect ConsequencesAnna Romaguera, Marta Torrens, Esther Papaseit, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Anales De Pediatria|May 10, 2023
Thalidomide, the story goes onEsther Papaseit, Magí Farré, Óscar Garcia-Algar
Current Opinion in Psychiatry|May 21, 2014
Emerging drugs in EuropeEsther Papaseit, Magí Farré, Fabrizio Schifano, et al.
Medicina Clinica|October 23, 2013
[Abuse-related adverse drug reactions and abuse deterrent formulations]Esther Papaseit, Clara Pérez-Mañá, Marta Torrens, et al.
Actas Espanolas De Psiquiatria|February 7, 2019
Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case reportPilar Alvarez, Esther Papaseit, Víctor Pérez, et al.
Medicina (Kaunas, Lithuania)|August 23, 2020
UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of ConsumersManuela Pellegrini, Emilia Marchei, Esther Papaseit, et al.
Pharmaceutics|March 27, 2025
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in HumansDolly Andrea Caicedo, Clara Pérez-Mañá, Magí Farré, et al.
Medicina Clinica|July 30, 2023
[The new trend of some inhalant use: Risks and warnings of false harmlessness]Jose Cárdenas-Quesada, Clara Pérez-Mañá, Esther Papaseit, et al.
JAMA Network Open|January 16, 2019
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysisMari Carmen Torres-Moreno, Esther Papaseit, Marta Torrens, et al.
CNS & Neurological Disorders Drug Targets|April 18, 2017
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and MedicinesAna Lucia Arellano, Esther Papaseit, Anna Romaguera, et al.
CNS & Neurological Disorders Drug Targets|April 26, 2017
Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect ConsequencesAnna Romaguera, Marta Torrens, Esther Papaseit, et al.
Pageof 9